Balyasny Asset Management
RARX

Balyasny Asset Management’s Ra Pharmaceuticals, Inc. Common Stock RARX Stock Holding History

Balyasny Asset Management’s Portfolio RARX Stock Details RARX Fund Activity
Upgrade to unlock
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q2 		– Sell
2020
Q1 		$15.7M Buy
2019
Q4 		$8.98M Buy
2018
Q2 		– Sell
2018
Q1 		$154K Sell
2017
Q4 		$286K Buy
2017
Q2 		– Sell
2017
Q1 		$302K Buy
2016
Q4 		$206K Buy